No authoritative reference available. No authoritative reference available. Based on hedge period reference price, the approximate amount recorded as a reduction to stockholders' equity pending final settlement of the accelerated shares repurchase agreement. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element may be used to capture the complete disclosure pertaining to an entity's basic and diluted earnings per share No authoritative reference available. No authoritative reference available. No authoritative reference available. Description of material license agreements entered into in the current period, in which the entity is a participant and a description of collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations under thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of contractual agreements that qualify as collaboration agreements under ASC 808-10. No authoritative reference available. No authoritative reference available. No authoritative reference available. The amount of upfront payment made for a license agreement and recorded to research and development expense. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. No authoritative reference available. This item represents the net unrealized holding gain or loss on available-for-sale securities that has been included in a separate component of shareholders' equity during the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The aggregate amount of noncash expense charged against earnings in the period to allocate the cost of intangible assets over their estimated remaining economic lives and the aggregate write down of all assets from carrying value to fair value. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amounts currently receivable other than from customers, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (government agency bonds) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (certificates of deposit) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (money market accounts) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the gross unrealized losses (excess of the carrying value over their fair value as of the reporting date) for available for sale securities, which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer. Included in other comprehensive income, unless designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis, which are recognized in earnings. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (corporate bonds) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the gross unrealized gains (excess of fair value over carrying value as of reporting date) for available for sale securities, which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer. Included in other comprehensive income in the statement of shareholders' equity, unless the Available-for-sale Security is designated as a fair value hedge in which case the gain shall be recognized in earnings during the period of the hedge. No authoritative reference available. No authoritative reference available. No authoritative reference available. Time period, prior to the expiration of a patent, where a company could launch a generic version of another company's product. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (municipal bonds and notes) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Period of time in which current and former sales representatives employed by the company in the State of New York may be included in the action. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The carrying amount as of the balance sheet date of a specific loss contingency reserve. No authoritative reference available. Describes legal proceedings that were reported in the period or disclosed as of the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (commercial paper) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the expense recognized during the period, net of tax, arising from share-based compensation arrangements (for example, shares of stock, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. No authoritative reference available. Options to purchase common stock that were outstanding during the period that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented. No authoritative reference available. The combined average purchase price per share under accelerated shares repurchase agreement. No authoritative reference available. No authoritative reference available. No authoritative reference available. Changes in the entity's income taxes that arise when compensation cost (from non-qualified stock options) recognized on the entity's tax return differs from compensation cost from non-qualified stock options recognized on the income statement. This element can increase or decrease net cash provided by operating activities. No authoritative reference available. Period of time in which current and former sales representatives employed by the company throughout the United States may be included in the action. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Description of the period of time over which an employee can exercise a grant of stock options, which may be expressed in a variety of ways (for example, in years, month and year). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amount of obligation for asset recorded to license agreements, product rights and other intangibles No authoritative reference available. The portion of active product liability lawsuits naming the company that allege a violent event occurred due to product usage. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the gross unrealized gains (excess of fair value over carrying value as of reporting date) for available for sale securities, which are intended be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Included in other comprehensive income in the statement of shareholders' equity, unless the Available-for-sale Security is designated as a fair value hedge in which case the gain shall be recognized in earnings during the period of the hedge. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The amount of potential future upfront and milestone payments for a license or collaboration agreement. No authoritative reference available. Includes the detail of accounts receivable and other receivables, net of allowance for doubtful accounts. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the gross unrealized losses (excess of the carrying value over their fair value as of the reporting date) for available for sale securities, which are intended be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Included in other comprehensive income, unless designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis, which are recognized in earnings. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the disclosure of the contractual maturity of investments in certain debt securities that are neither classified as trading or held-to-maturity securities, at the estimated fair value. A debt security represents a creditor relationship with an enterprise. debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. No authoritative reference available. No authoritative reference available. No authoritative reference available. The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage pursuant to the settlement agreement with the USAO and the DOJ. No authoritative reference available. Number of previously disclosed qui tam lawsuits the company has settled with the USAO and the DOJ. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of shares that were delivered in the period under an accelerated shares repurchase agreement. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of product liability lawsuits with an agreement in principle. No authoritative reference available. Summary of net sales by therapeutic class. No authoritative reference available. This element represents a certain statement of financial position asset caption (variable rate demand notes) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of active product liability lawsuits naming the company. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (auction rate securities) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a summary of inventories, net of reserves for obsolescence. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element represents a certain statement of financial position asset caption (floating rate notes) which represents a class of assets, or which may include an individual asset, measured at fair value on a recurring basis. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available.